about
P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC)P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value.Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case reportCross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma.Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromesEGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center.p95HER2 truncated form in resected non-small cell lung cancermicroRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours.Glomus tumor of the shoulder: A case report and review of the literature.Histo-cytological diagnostic accuracy in lung cancer.Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases.CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.EML4-ALK translocation in both metachronous second primary lung sarcomatoid carcinoma and lung adenocarcinoma: a case report.Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer.Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.Advances in molecular diagnostics for mitochondrial diseases.Expression of p-AKT and p-mTOR in a large series of bronchopulmonary neuroendocrine tumors.ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.An "inflammatory" mitochondrial myopathy. A case report.Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas.Expression of endothelin 1 and its angiogenic role in meningiomas.Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.Simultaneous penile and signet ring cell bladder carcinoma in renal transplant recipient: a first case.Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular featuresDiscordant somatic and germlineVEGF-Agenotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasisTryptase Mast Cells in Malignant Pleural Mesothelioma as an Independent Favorable Prognostic FactorNerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatmentEffect of mesenchymal stem cell penile transplantation on erectile signaling of aged ratsPseudodiverticula of ureter: radiologic and histologic findings
P50
Q34152239-BBF545E5-C9A0-46EB-BB06-99CD23A33A69Q34583795-DB3BEA76-0BDB-4F5F-BEAC-1C4E6B00BE72Q35167477-FAD1B72A-F420-48FE-B55A-8D4F14909312Q35964491-EBCE9DE7-2F7A-4C80-9ED4-4B30E44674F2Q35985502-497CA0F7-2964-4299-95F9-A047C72ACC1FQ36066994-5CC75715-DB98-4523-B29C-620957B887B5Q36170889-CE9DD914-6C8F-4216-9943-CA9744C09C05Q36354817-AD71C6FB-CC6F-4D31-B1DB-C93FBA3B8F92Q36642695-6443D7B2-331B-4FB9-9C23-D0465CB6A5C4Q37229361-7BE0009F-29DF-4826-8C77-894C4EFBA322Q38164052-7F20AD08-6A86-40A0-B238-86DCFE364BBFQ38217384-92C8C0FD-C919-4A4F-86BF-FD4F5BF83460Q39406065-E45F2DD2-DA52-46D9-B4B4-BE6313D98DFEQ39420886-8B77ECC4-D734-4483-9BD8-D520EE9BEF2CQ39621487-47BA0ED1-E2A6-4946-BE65-D957E7D8DD36Q39810346-BC6DE65C-5599-4B46-8EC6-7801291FF1DAQ39951345-8D5F6BB6-FA24-4A5B-911B-83A7B46124D8Q43080122-F70735FA-E357-4B3C-8F1D-D7359DE04635Q46144361-6A861031-D0A4-4E63-8BDD-F5D9B0DBDB2EQ50486368-83232DAF-A801-4E4F-8BB2-833CFB4D2940Q53181008-2AA47FE3-1777-443E-BA17-3CA0700188A8Q53457621-1AF4D463-7E2C-40BC-93CF-A0C7DED6C856Q53930034-9521E82D-F0B2-4AD2-8A4B-CAD75A391FF6Q54241216-2E291DC1-7921-492B-B9FB-B24F5DAD18A9Q54367113-4C4F45FA-9225-4B9D-B76C-4536146DFDCAQ55043090-A1A513E0-4E5B-419F-9350-64E89EC9DE2BQ59218961-21162E2A-E834-4795-B65F-CC3442EDEDEDQ59219080-7F2B8F37-D93F-4980-9D82-0294045A1091Q59219098-50932348-0FEF-4B74-BB1E-5339019A18F7Q60327245-8B1A925C-E267-425A-A86E-1DF8947E89BFQ61827146-92619BAE-0E11-461C-BDCA-8A07D661E1D5Q79702383-885ECA16-5B64-437E-B592-800CE509BC47
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Greta Ali
@ast
Greta Ali
@nl
Greta Alì
@en
Greta Alì
@es
type
label
Greta Ali
@ast
Greta Ali
@nl
Greta Alì
@en
Greta Alì
@es
altLabel
Greta Ali
@en
prefLabel
Greta Ali
@ast
Greta Ali
@nl
Greta Alì
@en
Greta Alì
@es
P1053
J-9642-2016
P106
P1153
14064429700
P2038
P21
P31
P3829
P496
0000-0001-9258-3466